180 related articles for article (PubMed ID: 29097800)
1. HIF-1α- Targeting Acriflavine Provides Long Term Survival and Radiological Tumor Response in Brain Cancer Therapy.
Mangraviti A; Raghavan T; Volpin F; Skuli N; Gullotti D; Zhou J; Asnaghi L; Sankey E; Liu A; Wang Y; Lee DH; Gorelick N; Serra R; Peters M; Schriefer D; Delaspre F; Rodriguez FJ; Eberhart CG; Brem H; Olivi A; Tyler B
Sci Rep; 2017 Nov; 7(1):14978. PubMed ID: 29097800
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of hypoxia inducible factor 1 and topoisomerase with acriflavine sensitizes perihilar cholangiocarcinomas to photodynamic therapy.
Weijer R; Broekgaarden M; Krekorian M; Alles LK; van Wijk AC; Mackaaij C; Verheij J; van der Wal AC; van Gulik TM; Storm G; Heger M
Oncotarget; 2016 Jan; 7(3):3341-56. PubMed ID: 26657503
[TBL] [Abstract][Full Text] [Related]
3. Cycling hypoxia increases U87 glioma cell radioresistance via ROS induced higher and long-term HIF-1 signal transduction activity.
Hsieh CH; Lee CH; Liang JA; Yu CY; Shyu WC
Oncol Rep; 2010 Dec; 24(6):1629-36. PubMed ID: 21042761
[TBL] [Abstract][Full Text] [Related]
4. Silencing hypoxia-inducible factor-1alpha inhibits cell migration and invasion under hypoxic environment in malignant gliomas.
Fujiwara S; Nakagawa K; Harada H; Nagato S; Furukawa K; Teraoka M; Seno T; Oka K; Iwata S; Ohnishi T
Int J Oncol; 2007 Apr; 30(4):793-802. PubMed ID: 17332917
[TBL] [Abstract][Full Text] [Related]
5. RNA interference targeting hypoxia-inducible factor 1α via a novel multifunctional surfactant attenuates glioma growth in an intracranial mouse model.
Gillespie DL; Aguirre MT; Ravichandran S; Leishman LL; Berrondo C; Gamboa JT; Wang L; King R; Wang X; Tan M; Malamas A; Lu ZR; Jensen RL
J Neurosurg; 2015 Feb; 122(2):331-41. PubMed ID: 25423275
[TBL] [Abstract][Full Text] [Related]
6. Hypoxia promotes glioma-associated macrophage infiltration via periostin and subsequent M2 polarization by upregulating TGF-beta and M-CSFR.
Guo X; Xue H; Shao Q; Wang J; Guo X; Chen X; Zhang J; Xu S; Li T; Zhang P; Gao X; Qiu W; Liu Q; Li G
Oncotarget; 2016 Dec; 7(49):80521-80542. PubMed ID: 27602954
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of hypoxia inducible factor 1alpha causes oxygen-independent cytotoxicity and induces p53 independent apoptosis in glioblastoma cells.
Dai S; Huang ML; Hsu CY; Chao KS
Int J Radiat Oncol Biol Phys; 2003 Mar; 55(4):1027-36. PubMed ID: 12605983
[TBL] [Abstract][Full Text] [Related]
8. Combined intracranial Acriflavine, temozolomide and radiation extends survival in a rat glioma model.
Serra R; Mangraviti A; Gorelick NL; Shapira-Furman T; Alomari S; Cecia A; Darjee N; Brem H; Rottenberg Y; Domb AJ; Tyler B
Eur J Pharm Biopharm; 2022 Jan; 170():179-186. PubMed ID: 34968646
[TBL] [Abstract][Full Text] [Related]
9. The HIF-1 antagonist acriflavine: visualization in retina and suppression of ocular neovascularization.
Zeng M; Shen J; Liu Y; Lu LY; Ding K; Fortmann SD; Khan M; Wang J; Hackett SF; Semenza GL; Campochiaro PA
J Mol Med (Berl); 2017 Apr; 95(4):417-429. PubMed ID: 28004126
[TBL] [Abstract][Full Text] [Related]
10. Identification of imaging biomarkers for the assessment of tumour response to different treatments in a preclinical glioma model.
Lo Dico A; Martelli C; Valtorta S; Raccagni I; Diceglie C; Belloli S; Gianelli U; Vaira V; Politi LS; Bosari S; Lucignani G; Moresco RM; Ottobrini L
Eur J Nucl Med Mol Imaging; 2015 Jun; 42(7):1093-105. PubMed ID: 25813354
[TBL] [Abstract][Full Text] [Related]
11. Downregulation of HIF-1a sensitizes U251 glioma cells to the temozolomide (TMZ) treatment.
Tang JH; Ma ZX; Huang GH; Xu QF; Xiang Y; Li N; Sidlauskas K; Zhang EE; Lv SQ
Exp Cell Res; 2016 May; 343(2):148-158. PubMed ID: 27090014
[TBL] [Abstract][Full Text] [Related]
12. Expression patterns of the hypoxia-related genes osteopontin, CA9, erythropoietin, VEGF and HIF-1alpha in human glioma in vitro and in vivo.
Said HM; Hagemann C; Staab A; Stojic J; Kühnel S; Vince GH; Flentje M; Roosen K; Vordermark D
Radiother Oncol; 2007 Jun; 83(3):398-405. PubMed ID: 17524506
[TBL] [Abstract][Full Text] [Related]
13. The expression and significance of HIF-1alpha and GLUT-3 in glioma.
Liu Y; Li YM; Tian RF; Liu WP; Fei Z; Long QF; Wang XA; Zhang X
Brain Res; 2009 Dec; 1304():149-54. PubMed ID: 19782666
[TBL] [Abstract][Full Text] [Related]
14. Flavopiridol downregulates hypoxia-mediated hypoxia-inducible factor-1alpha expression in human glioma cells by a proteasome-independent pathway: implications for in vivo therapy.
Newcomb EW; Ali MA; Schnee T; Lan L; Lukyanov Y; Fowkes M; Miller DC; Zagzag D
Neuro Oncol; 2005 Jul; 7(3):225-35. PubMed ID: 16053697
[TBL] [Abstract][Full Text] [Related]
15. Noscapine inhibits hypoxia-mediated HIF-1alpha expression andangiogenesis in vitro: a novel function for an old drug.
Newcomb EW; Lukyanov Y; Schnee T; Ali MA; Lan L; Zagzag D
Int J Oncol; 2006 May; 28(5):1121-30. PubMed ID: 16596228
[TBL] [Abstract][Full Text] [Related]
16. Relationship of 14-3-3zeta (ζ), HIF-1α, and VEGF expression in human brain gliomas.
Cao WD; Kawai N; Miyake K; Zhang X; Fei Z; Tamiya T
Brain Tumor Pathol; 2014 Jan; 31(1):1-10. PubMed ID: 23358800
[TBL] [Abstract][Full Text] [Related]
17. A perylene derivative regulates HIF-1α and Stat3 signaling pathways.
Chen H; Guan Y; Yuan G; Zhang Q; Jing N
Bioorg Med Chem; 2014 Feb; 22(4):1496-505. PubMed ID: 24485121
[TBL] [Abstract][Full Text] [Related]
18. Current insights and future perspectives of hypoxia-inducible factor-targeted therapy in cancer.
Ajith TA
J Basic Clin Physiol Pharmacol; 2018 Dec; 30(1):11-18. PubMed ID: 30260792
[TBL] [Abstract][Full Text] [Related]
19. Hypoxia promotes expansion of the CD133-positive glioma stem cells through activation of HIF-1alpha.
Soeda A; Park M; Lee D; Mintz A; Androutsellis-Theotokis A; McKay RD; Engh J; Iwama T; Kunisada T; Kassam AB; Pollack IF; Park DM
Oncogene; 2009 Nov; 28(45):3949-59. PubMed ID: 19718046
[TBL] [Abstract][Full Text] [Related]
20. Multimodal targeting of tumor vasculature and cancer stem-like cells in sarcomas with VEGF-A inhibition, HIF-1α inhibition, and hypoxia-activated chemotherapy.
Yoon C; Chang KK; Lee JH; Tap WD; Hart CP; Simon MC; Yoon SS
Oncotarget; 2016 Jul; 7(28):42844-42858. PubMed ID: 27374091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]